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Abstract Preadipocytes are present and can proliferate to in-
crease fat mass throughout adult life. The importance of mito-
chondria in these cells has never been investigated, although we
recently reported that mitochondrial oxidative metabolism is
non-negligible in white preadipocytes. Mitochondrial reactive
oxygen species generation is intimately associated with respira-
tory chain function. An increasing number of reports support
their role as signalling molecules. The aim of this work was to
study the e¡ects of mitochondrial reactive oxygen species on
proliferation of white preadipocytes. Rotenone and oligomycin,
inhibitors of complex I and of ATP synthase respectively, in-
creased H2O2 and inhibited cell growth of preadipocytes (with-
out inducing necrosis or apoptosis). These e¡ects were partly
prevented by addition of radical scavengers. A chemical uncou-
pler had opposite e¡ects on reactive oxygen species generation
and cell growth. Propofol, which inhibits complex I but also
scavenges free radicals, had e¡ects similar to those of the un-
coupler on both parameters. Thus, mitochondrial reactive oxy-
gen species can in£uence development of adipose tissue by af-
fecting the size of the white preadipocyte pool.
) 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
Key words: White preadipocyte; Proliferation;
Mitochondrion; Reactive oxygen species
1. Introduction
White fat development is critical for energy homeostasis. It
depends on the preadipocyte pool and varies considerably ac-
cording to physiological and pathophysiological conditions
[1]. White preadipocytes were believed to have very low mi-
tochondrial oxidative metabolism, although we and others
demonstrated that these cells have a non-negligible mitochon-
drial apparatus and associated functions [2,3].
The mitochondrial electron transport chain accounts for
85^90% of the O2 consumed in the cell and approximately
1^3% of this O2 is incompletely metabolized and diverted
into superoxide anion (Oc32 ) [4,5]. O
c3
2 and subsequently gen-
erated species, hydroxyl radicals, cOH and hydrogen peroxide,
H2O2 constitute reactive oxygen species (ROS). This release of
ROS is obligatory and varies with the redox state of the elec-
tron carriers according to the mitochondrial oxidative metab-
olism [6,7].
Many investigations of the consequences of ROS genera-
tion on proliferation have been performed in various cell
types. Opposite e¡ects have been reported depending on the
cell type or the yield of ROS production [8^10]. For instance,
although H2O2 was suggested to act as a positive signal for
proliferation in BALB/3T3 mouse ¢broblast cells, it can act as
a negative signal in mouse osteoblast cells (MC3T3) [8]. Para-
doxically, antioxidants (K-tocopherol) and oxidants (H2O2)
have the same e¡ect on cell growth [9]. Even though numer-
ous studies report strong extracellular generation of ROS (ad-
dition of H2O2 or xanthine/xanthine oxidase), most evidence
suggests that the intensity and subcellular origin of ROS gen-
eration must be crucial in their e¡ect on cell fate. The con-
tinuous release of mitochondrial oxidants has generally been
considered in the context of degenerative diseases and aging
[11]. However, the concept that mitochondrial ROS also func-
tion as signalling molecules is now emerging [7,12].
In this work, we hypothesized and then demonstrated that
mitochondrial ROS in£uence white preadipocyte prolifera-
tion.
2. Materials and methods
2.1. Compounds
All chemical compounds were purchased from Sigma (L’Isle
d’Abeau Chesnes, France). Ethanol was used as solvent to achieve a
¢nal ethanol concentration in cell cultures of 0.4%. Dihydrorhod-
amine 123 (DHR123) was purchased from Molecular Probes (Eugene,
OR, USA)
2.2. Cell culture conditions
3T3-L1 preadipocytes were routinely cultivated in Dulbecco’s modi-
¢ed Eagle’s medium (DMEM) supplemented with 10% heat-inacti-
vated fetal bovine serum (FBS), L-glutamine (5 mM), amphotericin
B (5 ng/ml), streptomycin (2 Wg/ml) and penicillin (50 WU/ml), at 37‡C
in a 5% CO2 humidi¢ed atmosphere. 3T3-L1 cells were seeded at a
density of 4500 cells/cm2 in DMEM supplemented with 10% FBS.
For primary culture of human stroma-vascular cells (SVC), samples
of human subcutaneous adipose tissue were obtained from non-obese
women and men undergoing abdominal dermolipectomy in the De-
partment of Plastic Surgery of Toulouse Rangueil Hospital. The study
was approved by the Ethical Committee of Toulouse University Hos-
pital. SVC cells were puri¢ed and cultured as previously described
[13], then seeded at 45 000 cells/cm2.
For both cultures, mitochondrial inhibitors or carbonyl cyanide
chlorophenylhydrazone (CCCP) were added to medium after 48 h
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of culture. Radical scavengers were added 1 h before the addition of
mitochondrial inhibitors.
2.3. Assessment of cell proliferation
Cell number was determined using a Coulter counter Z2. For the
DNA synthesis assay [14], cells were pulsed with [3H]thymidine (1 WCi/
ml) and carrier thymidine to a ¢nal concentration of 2.5 WM for 1 h
(3T3-L1) or 3 h (human SVC). The cells were washed twice with
phosphate-bu¡ered saline (PBS) and 5% trichloroacetic acid was
added. After washing with 90% ethanol, the acid-insoluble fraction
was dissolved in 0.5 ml of 0.1 M NaOH and then processed for
scintillation counting.
2.4. Determination of intracellular ROS generation
Intracellular ROS generation was assessed using DHR123 or 6-car-
boxy-2P,7P-dichlorodihydro£uorescein diacetate (H2-DCFDA) [15].
Cells were loaded with DHR123 (5 WM) or H2-DCFDA (2 WM) 30
min before the end of the incubation period (2 h). After washing twice
with PBS, cells were scraped and disrupted by sonication on ice (20 s).
Fluorescence (excitation 520 or 493 nm, emission 543 or 527 nm for
DHR123 and H2-DCFDA respectively) and protein content were then
measured [16]. The intensity of £uorescence was expressed as arbitrary
units per mg protein.
2.5. Determination of mitochondrial membrane potential
The uptake of rhodamine 123 by cells, used as an index of mito-
chondrial membrane potential, was determined under conditions pre-
viously described [17]. Cells were incubated with 5 WM rhodamine 123
for 30 min and then treated as for determination of intracellular ROS
generation. Then the £uorescence (excitation 520 nm, emission 543
nm) was measured.
2.6. Statistical analysis
MeansQS.E.M. were calculated and statistically signi¢cant di¡er-
ences between two groups were determined by Student’s t-test at
P6 0.05.
3. Results
3.1. Reversion by radical scavengers of rotenone e¡ects on
3T3-L1 preadipocyte proliferation and ROS generation
3T3-L1 preadipocytes were cultured in the presence of ro-
tenone at increasing concentrations. Fig. 1A shows that, com-
pared with controls, rotenone reduced the cell number in a
dose-dependent manner. At concentrations up to 4U1037 M,
a reduction in the cell number occurred without a¡ecting via-
bility: no apoptotic or necrotic processes were observed when
cells were stained with Syto 13 and propidium iodide [18]
(data not shown). Similar results were observed with
[3H]thymidine incorporation. For example, at the concentra-
tion which gave a 50% reduction in cell number (4U1037 M),
rotenone signi¢cantly (P6 0.001) decreased [3H]thymidine in-
corporation (Fig. 1B). On incubation of preadipocytes with
this rotenone concentration, we observed a signi¢cant increase
of ROS generation, assessed by measurements of H2-DCFDA
£uorescence (159Q 10.6%, P6 0.001, Fig. 1C) as well as
DHR123 £uorescence (169Q 7.4%, P6 0.001, Fig. 1D).
Two radical scavengers, butylhydroxyanisole (BHA) and
trolox, were tested to counteract ROS generation and rote-
none inhibition of preadipocyte proliferation. For this pur-
pose, the highest concentrations of BHA (1035 M) and trolox
(5U1034 M) which had no e¡ect per se on [3H]thymidine
incorporation and cell number were determined and used
(data not shown). The increase of DHR123 £uorescence in-
duced by rotenone was signi¢cantly (P6 0.01) lowered when
BHA or trolox was added to the culture medium (124Q 2%
and 124Q 4% respectively) (Fig. 1E). In contrast, BHA or
trolox increased [3H]thymidine incorporation in supplemented
cells (42Q 8% and 51Q4% respectively) compared to treat-
ment with rotenone alone (30Q 1%), trolox being more e¡ec-
tive (Fig. 1F). The prevention of the rotenone e¡ect by radical
scavengers was partial but was nevertheless strongly signi¢-
cant (P6 0.01). Cell number was also signi¢cantly increased
in BHA- and trolox-supplemented cells (64Q 2% and
68Q 1.5% respectively) compared to treatment with rotenone
alone (50 Q 0.18%) (P6 0.01, n=4, data not shown). Another
radical scavenger (butylhydroxytoluene) and a thiol reductive
agent (pyrrolidine dithiocarbamate) were also e¡ective in
counteracting ROS generation but they were not selected be-
cause they slightly changed [3H]thymidine incorporation when
they were added alone.
Similar results were obtained with human SVC. Rotenone
signi¢cantly (P6 0.001) decreased [3H]thymidine incorpora-
tion and the addition of BHA or trolox partly prevented the
inhibition induced by rotenone (80.1 Q 3.6%, P6 0.05, and
Fig. 1. Reversion by radical scavengers of rotenone e¡ects on 3T3-
L1 preadipocyte proliferation and ROS generation. A: 3T3-L1 pre-
adipocytes were cultured with increasing concentrations of rotenone.
After 24 h incubation, cells were collected by trypsinization and
counted. B: 3T3-L1 preadipocytes were incubated with or without
4U1037 M rotenone for 24 h and then the thymidine incorporated
over 1 h was measured. C,D: 3T3-L1 preadipocytes were incubated
for 2 h in the presence of 4U1037 M rotenone. Thirty minutes be-
fore the end of the incubation period, cells were loaded with H2-
DCFDA (C) or DHR123 (D). Fluorescence was expressed as arbi-
trary units per mg protein. E: 3T3-L1 preadipocytes were preincu-
bated for 1 h with 1035 M BHA or 5U1034 M trolox and then
treated as described in D. F: 3T3-L1 preadipocytes were preincu-
bated for 1 h with 1035 M BHA or 5U1034 M trolox and then the
thymidine incorporated over 1 h was measured. Data are the
meanQS.E.M. of n=3 (A) or n=5 (B^F) independent experiments
(each experiment in triplicate). ***P6 0.001 versus control,
##P6 0.01 versus rotenone.
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73.7Q 0.8%, P6 0.05 respectively) compared to treatment
with rotenone alone (63 Q 3.8%) (data not shown).
3.2. E¡ects of oligomycin on 3T3-L1 preadipocyte proliferation
and ROS generation
To validate the results obtained with rotenone, we modu-
lated ROS generation in a way which did not involve inhib-
itors of respiratory chain components. In the presence of oli-
gomycin (an ATP synthase inhibitor), the cell number was
dose-dependently reduced, compared with controls. The con-
centration which reduced the cell number by 50% (4U1039
M) was chosen (Fig. 2A). At this concentration, cell viability
(necrosis and apoptosis) was not a¡ected (data not shown).
On incubation with oligomycin, there was a signi¢cant in-
crease in H2-DCFDA £uorescence (142Q 7.9%, P6 0.001,
Fig. 2C) as well as in DHR123 £uorescence (145Q 17.8%,
P6 0.05, Fig. 2D) and a signi¢cant (P6 0.01) decrease in
[3H]thymidine incorporation in preadipocytes (Fig. 2B). The
addition of BHA or trolox partly but signi¢cantly prevented
the e¡ect of oligomycin on [3H]thymidine incorporation
(68Q 7.8% and 75Q4.5%, P6 0.05 and P6 0.001 respectively)
compared with treatment with oligomycin alone (44Q 5.1%)
(Fig. 2E).
3.3. E¡ects of CCCP on 3T3-L1 preadipocyte proliferation,
rhodamine uptake and ROS generation
In contrast, in the presence of the chemical uncoupler
CCCP, at 5U1039 M, there was a signi¢cant decrease in rho-
damine 123 uptake (80.7 Q 1.2%, P6 0.001, Fig. 3A) associ-
ated with a decrease in H2-DCFDA £uorescence
(71.33Q 6.2%, P6 0.001, Fig. 3B) as well as in DHR123 £uo-
rescence (73.87Q 3.6%, P6 0.001, Fig. 3C). CCCP also signif-
icantly increased cell number (114Q 2%, P6 0.001, Fig. 3D)
and [3H]thymidine incorporation (115Q 2.3%, P6 0.001, Fig.
3E).
3.4. Comparative e¡ects of rotenone and propofol on 3T3-L1
preadipocyte proliferation and ROS generation
To de¢nitively demonstrate the involvement of ROS, in a
di¡erent approach, we used another inhibitor of complex I,
propofol [19], which also has the ability to scavenge free rad-
icals [20]. The e¡ects of rotenone and propofol on cell respi-
Fig. 2. E¡ects of oligomycin on 3T3-L1 preadipocyte proliferation
and ROS generation. Reversion by radical scavengers. A: 3T3-L1
preadipocytes were incubated for 24 h with or without 4U1039 M
oligomycin and then treated as described in Fig. 1A. B: 3T3-L1 pre-
adipocytes were incubated with or without 4U1039 M oligomycin
for 24 h and then the thymidine incorporated over 1 h was mea-
sured. C,D: 3T3-L1 preadipocytes were incubated for 2 h with or
without 4U1039 M oligomycin and then treated as described in
Fig. 1C,1D. E: 3T3-L1 preadipocytes were preincubated for 1 h
with 1035 M BHA or 5U1034 M trolox and then the thymidine in-
corporated over 1 h was measured. Data are the meanQS.E.M. of
n=5 independent experiments (each experiment in triplicate).
*P6 0.05, **P6 0.01 and ***P6 0.001 versus control; #P6 0.05
and ###P6 0.001 versus oligomycin.
Fig. 3. E¡ects of CCCP on 3T3-L1 preadipocyte proliferation, rho-
damine 123 uptake and ROS generation. A: 3T3-L1 preadipocytes
were incubated for 30 min with rhodamine 123. Fifteen minutes be-
fore the end of the incubation period, 5U1039 M CCCP was added.
Fluorescence was expressed as arbitrary units per mg protein.
B,C: 3T3-L1 preadipocytes were incubated for 2 h with or without
5U1039 M CCCP and then treated as described in Fig. 1C,D.
D: 3T3-L1 preadipocytes were incubated with or without 5U1039
M CCCP for 24 h and then treated as described in Fig. 1A. E: 3T3-
L1 preadipocytes were incubated with or without 5U1039 M CCCP
for 24 h and then the thymidine incorporated over 1 h was mea-
sured. Data are the meanQS.E.M. of n=5 independent experiments
(each experiment in triplicate). ***P6 0.001 versus control.
FEBS 27561 13-8-03
A. Carrie're et al./FEBS Letters 550 (2003) 163^167 165
ration at equiactive concentrations were compared. The oxy-
gen consumption of 3T3-L1 preadipocytes in suspension was
measured polarographically by means of a Clark-type oxygen
electrode. 4U1039 M rotenone and 1034 M propofol inhibited
respiration of cell suspensions by 50Q 2% (data not shown).
Fig. 4 shows the opposite e¡ects of rotenone and propofol on
H2-DCFDA £uorescence, DHR123 £uorescence, cell number
and [3H]thymidine incorporation. In these conditions,
4U1039 M rotenone signi¢cantly increased H2-DCFDA £uo-
rescence (130Q 3%, P6 0.001, Fig. 4A) and DHR123 £uo-
rescence (146Q 3%, P6 0.001, Fig. 4B) but decreased cell
number (76Q 2%, P6 0.01, Fig. 4C) and [3H]thymidine incor-
poration (77Q 5%, P6 0.001, Fig. 4D). In contrast, 1034 M
propofol signi¢cantly decreased H2-DCFDA (78Q 7.3%,
P6 0.001, Fig. 4A) and DHR123 £uorescence (87.8 Q 3.2%,
P6 0.01, Fig. 4B) but increased cell number (121.8 Q 7%,
P6 0.01, Fig. 4C) and [3H]thymidine incorporation
(126Q 5.2%, P6 0.001, Fig. 4D).
4. Discussion
Numerous studies have investigated the role of ROS gen-
eration in the proliferation of various cells [8^10]. However,
most of these studies did not take into account the subcellular
origin of ROS. In white adipose tissue, the real importance of
ROS as well as that of mitochondrial biology is poorly
known. In this work, we attempted to demonstrate the e¡ects
of mitochondrial ROS on the proliferation of white adipocyte
precursors.
Contrary to the strong extracellular generation of ROS gen-
erally used, we induced moderate changes in mitochondrial
generation of ROS by di¡erent strategies. Oc32 generation is
intimately linked to electron transfer through the respiratory
chain. Rotenone and oligomycin, which inhibit complex I and
ATP synthase respectively, induce the accumulation of elec-
trons inside the respiratory chain in two di¡erent ways and
increase generation of Oc32 and subsequently of other ROS
(H2O2, cOH). As the use of mitochondrial inhibitors may
have some e¡ect on energetic status as well as on ROS gen-
eration, we developed several strategies to delineate the spe-
ci¢c e¡ect due to mitochondrial ROS. The ¢rst was to use
radical scavengers in combination with rotenone and oligomy-
cin. Second, the e¡ects of propofol and rotenone were com-
pared at concentrations equiactive on respiration. This is very
informative because, like rotenone, propofol acts on complex
I but also has the ability to powerfully scavenge free radicals
at the site of Oc32 generation. Lastly, we used a mitochondrial
uncoupler alone which is very e¡ective in decreasing mito-
chondrial ROS generation [12,21]. In preadipocytes, increase
of ROS level by rotenone indicates ROS generation by for-
ward and not by reverse electron transfer in the respiratory
chain, complex I being responsible [22].
Treatment of 3T3-L1 cells with rotenone reduced cell num-
ber as well as [3H]thymidine incorporation. This change in cell
growth is due to a decrease in cell proliferation because we
detected no apoptotic or necrotic events. Moreover, when
rotenone was removed from the medium (data not shown)
the cell number after 24 h was approximately 80% of control
indicating that the inhibition of 3T3-L1 preadipocyte prolif-
eration is a reversible phenomenon. Similar conclusions can
be drawn from the results of oligomycin treatment. Treatment
of 3T3-L1 cells with rotenone or oligomycin moderately en-
hanced generation of H2O2 (and other peroxides), which was
partly reversed by radical scavengers (BHA and trolox). This
is parallel to the inhibition of cell growth induced in the two
ways (inhibitors of complex I or ATP synthase) and the re-
version achieved by the same scavengers. Radical scavengers
only brought about partial reversion of the e¡ects of rotenone
and oligomycin on cell growth, which is consistent with the
less than total reversion of ROS generation by these mole-
cules. However, these experiments strongly suggest that mito-
chondrial ROS are partly responsible for inhibition of 3T3-L1
preadipocyte growth. The opposite e¡ects on ROS generation
and cell growth of rotenone and propofol (at concentrations
inducing similar inhibition of respiration) on the one hand,
and the e¡ects of an uncoupler, CCCP, on the other hand, are
complementary demonstrations of the importance of mito-
chondrial ROS in the inhibition of preadipocyte growth. A
similar conclusion was reached with human preadipocytes in
primary culture, suggesting that this conclusion is physiolog-
ically relevant in humans as well.
Preadipocyte proliferation is a key component of adipose
tissue development. Our results de¢nitively demonstrate that
the mitochondrial ROS produced, which re£ect constraints on
the respiratory chain and oxidative phosphorylation, act as
anti-growth signals on preadipocyte signalling. Moreover,
we demonstrated that mild uncoupling, by decreasing ROS
generation, slightly increases preadipocyte proliferation. It is
well established that for some cell types, ROS stimulate pro-
liferation [8]. We demonstrated that mitochondrial ROS have
the opposite e¡ect on white preadipocyte proliferation. The
inhibition of preadipocyte proliferation may well be a non-
Fig. 4. Comparative e¡ects of rotenone and propofol on 3T3-L1
preadipocyte proliferation and ROS generation. A,B: 3T3-L1 pre-
adipocytes were incubated for 2 h with or without 4U1039 M rote-
none or 1034 M propofol (these concentrations are equiactive on
mitochondrial respiration inhibition) and then treated as described
in Fig. 1C,D. C: 3T3-L1 preadipocytes were incubated with or
without 4U1039 M rotenone or 1034 M propofol for 24 h and
treated as described in Fig. 1A. D: 3T3-L1 preadipocytes were incu-
bated with or without 4U1039 M rotenone or 1034 M propofol for
24 h and then the thymidine incorporated over 1 h was measured.
Data are the meanQS.E.M. of n=6 independent experiments (each
experiment in triplicate). **P6 0.01 and ***P6 0.001 versus con-
trol.
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speci¢c consequence of damage to the complicated enzyme
system involved in proliferation.
This work emphasizes the importance of mitochondria in
the biology of white adipose tissue, which is largely neglected.
It establishes a direct link between oxidative metabolism and
the size of the adipocyte precursor pool which is consistent
with the adipose mass changes observed in metabolic disor-
ders such as obesity, diabetes and lipodystrophy.
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